A 3-month oral vitamin D supplementation marginally improves diastolic blood pressure in saudi patients with type 2 diabetes mellitus

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 12, 2014, Pages 5421-5428

  Al Zahrani, Mansour K ^a   Elnasieh, Abdulrahman M ^b   Alenezi, Farhan M ^b   Almoushawah, Abdulrahman A ^b   Almansour, Mohammed ^a   Alshahrani, Fahad ^b   Rahman, Saeed Ur ^b   Al Zahrani, Abdullah ^c  

^a College of Medicine Majmaa University ^*  (Saudi Arabia)

^b KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^c King Khaled National Guard   (Saudi Arabia)

Author keywords

Blood pressure; Diabetes mellitus type 2; Vitamin D deficiency; Vitamin D supplementation

Indexed keywords

COLECALCIFEROL; HEMOGLOBIN A1C;

ADULT; ARTICLE; CONTROLLED STUDY; DAIRY PRODUCT; DIASTOLIC BLOOD PRESSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COUNSELING; QUESTIONNAIRE; SAUDI; SUN EXPOSURE; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 84921489325     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Yousef M, Sabico SL, Chrousos GP. Diabetes mellitus type 2 and other chronic non-communicable diseases in the central region, Saudi Arabia (Riyadh cohort 2): a decade of an epidemic. BMC Med 2011; 9: 76.
2. Al-Musharaf S, Al-Othman A, Al-Daghri NM, Krishnaswamy S, Yusuf DS, Alkharfy KM, Al-Saleh Y, Al-Attas OS, Alokail MS, Moharram O, Yakout S, Sabico S, Chrousos GP. Vitamin D deficiency and calcium intake in reference to increased body mas index in children and adolescents. Eur J Pediatr 2012; 171: 1081-1086.
3. Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Yousef M, Nadhrah HM, Al-Othman A, Al-Saleh Y, Sabico S, Chrousos GP. Hypovitaminosis D and cardiometabolic risk factors among non-obese youth. Cent Eur J Med 2010; 5: 752-757.
4. Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Al-Othman A, Draz HM, Yakout SM, Al-Saleh Y, Al-Yousef M, Sabico S, Clerici M, Chrousos GP. Hypovitaminosis D associations with adverse metabolic parameters are accentuated in patients with type 2 diabetes mellitus: a body mass index-independent role of adiponectin? J Endocrinol Invest 2013; 36: 1-6.
5. Ardawi MS, Qari MH, Rouzi AA, Maimani AA, Raddadi RM. Vitamin D status in relation to obesity, bone mineral density, bone turnover markers and vitamin D receptor genotypes in healthy Saudi pre- and postmenopausal women. Osteoporos Int 2011; 22: 463-475.
6. Ardawi MS, Sibiany AM, Bakhsh TM, Qari MH, Maimani AA. High prevalence of vitamin D deficiency among healthy Saudi Arabian men: relationship to bone mineral density, parathyroid hormone, bone turnover markers and lifestyle factors. Osteoporos Int 2012; 23: 675-686.
7. Baynes KC, Boucher BJ, Feskens EJ, Kromhout D. Vitamin D, glucose tolerance and insulinaemia in elderly man. Diabetologia 1997; 40: 344-347.
8. Nyomba BL, Auwers J, Bormans V, Peeters TL, Pelemans W, Reynaert J, Bouillon R, Vantrappen G, De Moor P. Pancreatic secretion in man with subclinical vitamin D deficiency. Diabetologia 1986; 29: 34-38.
9. Orwoll E, Riddle M, Prince M. Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1994; 59: 1083-1087.
10. Teegarden D, Donkin SS. Vitamin D emerging new roles in insulin sensitivity. Nutr Res Rev 2009; 22: 82-92.
11. Penckofer S, Kouba J, Wallis DE, Emanuele MA. Vitamin D and Diabetes: Let the Sunshine In. Diabetes Educ 2008; 34: 939-940, 942, 944.
12. Scragg R, Sowers MF, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National and Nutrition Examination Survey. Diabetes Care 2004; 27: 2813-2818.
13. Fliser D, Stefanski A, Franek E, Fode P, Gudarzi A, Ritz E. No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects. Eur J Clin Invest 1997; 27: 629-633.
14. Inomata S, Kadowaki S, Yamatani T, Fukase M, Fujita T. Effect of 1-(OH)-vitamin D3 on insulin secretion in diabetes mellitus. Bone Miner 1986; 1: 187-192.
15. Ljunghall S, Lind L, Lithell H, Skarfors E, Selinus I, Sorensen OH, Wide L. Treatment with one-hydroxycholecalciferol in middle-aged men with impaired glucose tolerance-a prospective randomized double-blind study. Acta Med Scand 1987; 222: 361-367.
16. Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, El-Kholie E, Yousef M, Al-Othman A, Al-Saleh Y, Sabico S, Kumar S, Chrousos GP. Increased vitamin D supplementation recommended during summer in the gulf region: a counterintuitive seasonal effect in vitamin D levels in adult, overweight and obese Middle Eastern residents. Clin Endocrinol (Oxf) 2012; 76: 346-350.
17. Al-Daghri NM, Alkharfy KM, Al-Saleh Y, Al-Attas OS, Alokail MS, Al-Othman A, Moharram O, El-Kholie E, Sabico S, Kumar S, Chrousos GP. Modest reversal of metabolic syndrome manifestations with vitamin D status correction: a 12-month prospective study. Metabolism 2012; 61: 661-666.
18. Al-Daghri NM, Alkharfy KM, Al-Othman A, El-Kholie E, Moharram O, Alokail MS, Al-Saleh Y, Sabico S, Kumar S, Chrousos GP. Vitamin D supplementation as an adjuvant therapy for patients with T2DM: an 18-month prospective interventional study. Cardiovasc Diabetol 2012; 11: 85.
19. Alkharfy KM, Al-Daghri NM, Sabico SB, Al-Othman A, Moharram O, Alokail MS, Al-Saleh Y, Kumar S, Chrousos GP. Vitamin D supplementation in patients with diabetes mellitus type 2 on different therapeutic regimens: a one-year prospective study. Cardiovasc Diabetol 2013; 12: 113.
20. Jorde R, Figenschau Y. Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr 2009; 48: 349-354.
21. Patel P, Poretsky L, Liao E. Lack of effect of subtherapeutic vitamin D treatment on glycemic and lipid parameters in Type 2 diabetes: A pilot prospective randomized trial. J Diabetes 2010; 2: 36-40.
22. Holick MF, Siris ES, Binkley N, Beard MK, Khan A, Katzer JT, Petruschke RA, Chen E, de Papp AE. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005; 90: 3215-3224.
23. Lind L, Pollare T, Hvarfner A, Lithell H, Sørensen OH, Ljunghall S. Long-term treatment with active vitamin D (alphacalcidol) in middle-aged men with impaired glucose tolerance. Effects on insulin secretion and sensitivity, glucose tolerance and blood pressure. Diabetes Res 1989; 11: 141-147.
24. Nilas L, Christiansen C. Treatment with vitamin D or its analogues does not change body weight or blood glucose level in postmenopausal women. Int J Obes 1984; 8: 407-411.
25. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003; 326: 469-475.
26. Boon N, Hul GB, Sicard A, Kole E, Van Den Berg ER, Viguerie N, Langin D, Saris WH. The effects of increasing serum calcitriol on energy and fat metabolism and gene expression. Obesity 2006; 14: 1739-1746.
27. Scragg R, Slow S, Stewart AW, Jennings LC, Chambers ST, Priest PC, Florkowski CM, Camargo CA Jr, Murdoch DR. Long-term high-dose vitamin D3 supplementation and blood pressure in healthy adults: a randomized controlled trial. Hypertension 2014; 64: 725-30.
28. Witham MD, Ireland S, Houston JG, Gandy SJ, Waugh S, Macdonald TM, Mackenzie IS, Struthers AD. Vitamin D therapy to reduce blood pressure and left ventricular hypertrophy in resistant hypertension: randomized, controlled trial. Hypertension 2014; 63: 706-712.